Participated · Seed · Dec 2025

Ionic Wind is a St. Gallen–based spin-off from the Swiss Federal Laboratories for Materials Science and Technology (Empa) that creates cooling modules using high-voltage electric fields to move air without any mechanical parts. The solid-state design allows the cooling elements to be integrated directly into device housings, densely populated PCBs, or structural components, enabling quieter operation, higher reliability, and more compact product designs. Target applications include edge-AI systems, single-board computers, and industrial sensor modules that are bumping into thermal and spatial limitations with conventional fans. With fresh capital, the company plans to complete product certification, broaden its portfolio, and carry the solution through the final steps to market readiness. Mid-term, the technology could let hardware makers build more powerful, robust, and energy-efficient devices for the expanding edge-computing and industrial IoT markets. No revenue or user figures were disclosed in the article.

Participated · Series C · Aug 2023

Enough produces Abunda, a mycoprotein created by fermenting fungi fed on sugars from sustainably sourced grain; the product contains all nine essential amino acids, is high in protein and fibre, and has a neutral flavour suitable for meat, fish and dairy alternatives. The company says Abunda is up to fifteen times more efficient than protein from beef, generates zero-waste, and uses 97% fewer CO2 emissions than beef production. Enough opened a first-of-its-kind protein factory in Sas van Gent, Netherlands, with an initial capacity of 10,000 metric tonnes per year and plans to scale to more than 60,000 tonnes annually. Management positions the factory scale as the equivalent of growing one cow’s worth of protein every two minutes and says the capacity will support customers across the UK and Europe. The company intends to use the new funding to accelerate growth and scale production to become a global leader in sustainable protein. CEO Jim Laird framed the market as a multi-billion dollar opportunity and highlighted the environmental and ethical drivers for non-animal protein adoption. Enough produces Abunda, a mycoprotein fermented from fungi using renewable agricultural feedstocks (including grains) that the company sells B2B as a complete protein with all essential amino acids and high dietary fiber. Its customers and partners include Unilever (in the Vegetarian Butcher line) and Marks & Spencer. The Glasgow-based startup was founded in 2015 as a spin-out from the University of Strathclyde. Enough says it will scale production dramatically, building a first-of-its-kind protein biorefinery in the Netherlands that will start at 10,000 tonnes per year and ramp to more than 1 million tonnes by 2032. The company aims to grow 1 million tonnes of mycoprotein annually by 2032, projecting large livestock displacement and CO2 savings. Financially, Enough has secured a €42M ($51M) Series B and previously raised seed funding from DCVC, a £6.16M Series A, and a €17M Horizon 2020 grant.